Skip to content

Author

E. I. Obeagu

We have 4 of 342 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Unveiling the Molecular Mechanisms of Erythropoietin in HIV Pathogenesis: A Review

Erythropoietin is a glycoprotein hormone traditionally recognized for its central role in regulating erythropoiesis. Increasing evidence, however, highlights its pleiotropic effects in immunity, inflammation, and cellular protection, which are particularly relevant in the pathogenesis of human immunodeficiency virus in...

E. I. Obeagu, Okwudili B. Nwankwo · 0 citations
Review Open access Sep 2026

Integrations of Artificial Intelligence to Predict Breast Cancer Risk from Routine Blood Tests: A Narrative Review

Breast cancer remains a leading cause of cancer-related mortality globally, with early detection being vital for improving patient outcomes. Traditional diagnostic methods such as mammography and biopsy, although effective, have limitations including cost, invasiveness, and limited accessibility in resource-constrained...

E. I. Obeagu · 0 citations
Review Open access Feb 2026

Transcriptomic and epigenomic insights into ovarian cancer: a bioinformatics perspective – a narrative review

Ovarian cancer is a highly heterogeneous malignancy with complex molecular underpinnings that extend beyond genomic mutations to encompass transcriptomic and epigenomic alterations. Advances in next-generation sequencing and bioinformatics have enabled comprehensive profiling of gene expression patterns, non-coding RNA...

E. I. Obeagu · 0 citations
Review Open access Sep 2026

Circulating Tumor DNA in Breast Cancer: A Liquid Biopsy Revolution for Non-Invasive Genomic Profiling and Clinical Decision-Making

Breast cancer remains the most frequently diagnosed cancer and a leading cause of cancer-related mortality among women worldwide, underscoring the need for accurate, minimally invasive biomarkers to support precision oncology. Conventional tissue biopsy remains the standard for molecular characterization but is limited...

E. I. Obeagu, C. Okafor · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.